|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 344.75 USD | -0.67% |
|
+4.34% | +5.33% |
| 24/01 | The Market's Favorite Question Right Now: Is This a Return to Normal, or Just a Pause? |  |
| 23/01 | Bernstein Downgrades Amgen to Market Perform From Outperform, Price Target is $335 | MT |
| Capitalization | 186B 158B 146B 137B 255B 17,056B 270B 1,673B 664B 8,053B 696B 682B 29,293B | P/E ratio 2025 * |
26.9x | P/E ratio 2026 * | 25.6x |
|---|---|---|---|---|---|
| Enterprise value | 230B 196B 181B 170B 316B 21,148B 335B 2,074B 823B 9,985B 863B 845B 36,321B | EV / Sales 2025 * |
6.34x | EV / Sales 2026 * | 6.08x |
| Free-Float |
99.85% | Yield 2025 * |
2.77% | Yield 2026 * | 2.91% |
Last Transcript: Amgen Inc.
| 1 day | -0.67% | ||
| 1 week | +4.34% | ||
| Current month | +5.33% | ||
| 1 month | +4.00% | ||
| 3 months | +17.71% | ||
| 6 months | +11.49% | ||
| Current year | +5.33% |
| 1 week | 321.71 |  | 349.98 |
| 1 month | 318.21 | | 349.98 |
| Current year | 318.21 | | 349.98 |
| 1 year | 261.43 | | 349.98 |
| 3 years | 211.71 | | 349.98 |
| 5 years | 198.64 | | 349.98 |
| 10 years | 133.64 | | 349.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 01/01/2020 |
Esteban Santos
COO | Chief Operating Officer | 59 | 25/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.94% | 5.08% | 136 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.67% | +4.34% | +24.06% | +32.10% | 186B | |
| -2.12% | +2.49% | +38.83% | +211.00% | 953B | |
| +0.76% | +0.68% | +50.12% | +30.79% | 530B | |
| +0.53% | +2.29% | +28.47% | +47.60% | 388B | |
| +0.06% | -0.23% | +26.86% | +17.82% | 377B | |
| +0.15% | -3.36% | +22.94% | +23.03% | 286B | |
| +0.47% | +0.03% | +28.12% | +35.36% | 281B | |
| +1.17% | +3.20% | -30.92% | -16.86% | 281B | |
| -0.92% | -0.60% | +11.95% | -1.55% | 269B | |
| +3.65% | +8.82% | +46.29% | +63.32% | 169B | |
| Average | +0.31% | +1.55% | +24.67% | +44.26% | 371.91B | |
| Weighted average by Cap. | -0.17% | +1.27% | +28.51% | +72.76% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 36.32B 30.89B 28.63B 26.76B 49.88B 3,337B 52.87B 327B 130B 1,576B 136B 133B 5,731B | 36.98B 31.45B 29.15B 27.24B 50.78B 3,397B 53.82B 333B 132B 1,604B 139B 136B 5,835B |
| Net income | 6.99B 5.95B 5.51B 5.15B 9.6B 642B 10.18B 62.99B 25.01B 303B 26.22B 25.68B 1,103B | 7.02B 5.97B 5.54B 5.17B 9.65B 645B 10.22B 63.29B 25.13B 305B 26.34B 25.8B 1,108B |
| Net Debt | 44.53B 37.88B 35.11B 32.81B 61.16B 4,092B 64.82B 401B 159B 1,932B 167B 164B 7,027B | 39.18B 33.33B 30.89B 28.87B 53.81B 3,600B 57.04B 353B 140B 1,700B 147B 144B 6,183B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 344.75 $ | -0.67% | 2,024,980 |
| 22/01/26 | 347.07 $ | +1.01% | 3,025,150 |
| 21/01/26 | 343.60 $ | +3.81% | 4,148,714 |
| 20/01/26 | 331.00 $ | +0.18% | 2,947,821 |
| 16/01/26 | 330.41 $ | +0.12% | 4,033,805 |
Delayed Quote Nasdaq, 24 January 2026 at 08:00 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition